-
Cabotegravir and rilpivirine resistance-associated mutations among people with newly diagnosed HIV-1 in the Netherlands
Shalev, N., van Sighem, A. I., Bezemer, D. O., Juuriaans, S., van Kampen, J. J. A., van de Laar, T., Wensing, A. J. & van der Valk, M., 26 Jun 2026, (E-pub ahead of print) In: AIDS (London, England).Research output: Contribution to Journal › Article › Academic › peer-review
-
Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study
ATHENA National Observational Cohort Study, 1 Sept 2024, In: The Lancet HIV. 11, 9, p. e576-e585Research output: Contribution to Journal › Article › Academic › peer-review
-
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection
ANRS CO3 Aquitaine Cohort, the Swiss HIV Cohort Study, EuroSIDA & ATHENA Observational Cohort Study, May 2023, In: Journal of Hepatology. 78, 5, p. 947-957 11 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
